echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Junshi Biotech and AstraZeneca Pharmaceuticals signed an exclusive promotion agreement for Tuoyi

    Junshi Biotech and AstraZeneca Pharmaceuticals signed an exclusive promotion agreement for Tuoyi

    • Last Update: 2021-03-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 28th, Junshi Biopharmaceuticals announced that it had signed an "Exclusive Promotion Agreement" with AstraZeneca Pharmaceuticals Co.


    Junshi Biology will continue to be responsible for the promotion of other approved indications in core urban areas except for indications in the field of urinary tumors.


    According to the agreement, Junshi Bio will pay service fees to AstraZeneca in accordance with the agreement.


    After the agreement comes into effect, the initial period of the agreement is valid for 5 calendar years.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.